山东6城三甲医院要搞一票制

2018-01-02 佚名 赛柏蓝

山东省济南、青岛、东营、潍坊、威海、滨州6个试点城市三级甲等综合医院将试行“一票制”。

山东省济南、青岛、东营、潍坊、威海、滨州6个试点城市三级甲等综合医院将试行“一票制”。

有业内人士评论称在两票制背景下,大型商业受益,中小型商业受损,在一票制政策下,所有传统商业都将受损。

即使如此,山东部分城市一票制还是真的来了,而这也印证了此前一商业配送公司高层领导向赛柏蓝作出的推测。

▍一票制大盘点

根据各省公开信息,目前,已经有多省市明确鼓励一票制,其中一些地区甚至已开始实施一票制。

国家政策

2015 年,国家颁布《国务院办公厅关于完善公立医院药品集中采购工作的指导意见》( 简称7 号文),鼓励实施“一票制”。

福建省

2016年3月16日,福建三明市《关于进一步规范医疗设备采购的通知(明卫〔2016〕32号)》,明确医疗设备生产企业(或进口设备全国总代理商)直接开具增值税发票到医疗卫生机构,不允许到第三方过票、洗钱。”

2017年1月1日,福建实行耗材两票制,目前基础输液采购要求一票制。8月31日,福建省人民政府办公厅发布了《关于进一步改革完善药品生产流通使用政策的实施意见》,其中明确提到:在全省全面推行药品采购“两票制”,鼓励实行“一票制”。

浙江省

2016年6月1日,被称为信息流、商流、资金流“三流合一”的药械采购平台上线。首批试点医疗机构共有15家。其后的8个月内,分3批扩至全省。2017年11月11日,浙江省医用耗材采购新平台上线试运行。

湖北省

2017年5月23日,湖北省委、 省政府就《关于深入推进价格机制改革的实施意见》进行解读。明确大力推进医药产品采购机制改革,加快建立全省统一的医药产品电子交易平台,鼓励医药产品购销实行 “一票制” 。

山西省

2017年6月28日,山西省卫计委发布了《关于印发山西省“十三五”深化医药卫生体制改革规划暨实施方案的通知》,“鼓励生产企业直接为医疗机构配送药品,实现“一票制”。

陕西省

2017年7月5日和8月2日,位于陕西省内的三甲医院,也是医改试点医院,安康市中心医院连续发布了两条公告,明确16种医用耗材产品要执行“一票制”。

2017年8月21日,陕西省人民政府印发了《陕西省“十三五”深化医药卫生体制改革实施方案》,其中明确提出:城市公立医疗机构要全面实行药品耗材“两票制”,鼓励“一票制”,压缩配送企业数量。

天津市

2017年8月2日,天津印发《天津市深化医药卫生体制综合改革2017年重点工作任务》,明确全面推行药品采购从生产企业到流通企业、从流通企业到医疗卫生机构各开一次发票的“两票制”,探索医疗卫生机构与生产企业直接结算药品和耗材货款、生产企业与配送企业结算配送费用的“一票制”,压缩中间环节,降低虚高价格。

江苏泰州

2017年8月14日,泰州市卫计委发布《泰州市公立医疗卫生机构医用耗材采购配送管理办法》,生产企业具备医疗器械配送条件的,经泰州市卫生和计划生育委员会备案后可以向公立医疗卫生机构直供产品,实行“一票制”;不能直供的应选择一家泰州市公布的有资质的配送商确定配送关系,实行“两票制”。

河南漯河

2017年8月17日,人民网发表文章《应对城市医院“看病贵” 漯河开出特色“药方”》。其中,漯河市卫计委主任吴树清表示,“下一步我们还将探索药品采购一票制,也就是直接从药厂采购,为的就是省去流通中会造成药价增加的环节。”

山东省

2017年9月18日,《山东省公立医疗机构药品采购推行“两票制”实施方案(试行)》出台,全面推行“两票制”,鼓励试点“一票制”,严格控制“第三票”。

方案指出,2017年11月1日前,济南、青岛、东营、潍坊、威海、滨州6个医改试点城市率先启动“两票制”。

方案明确,在三级甲等综合医院选择部分用量较大、市场供应渠道简单的药品,由生产企业自愿作出承诺,医疗机构优先进行选择,试行“一票制”(医疗机构与药品生产企业直接结算货款、药品生产企业自行或委托配送,药品生产企业到医疗机构开一次发票)。

2017年10月26日,山东潍坊市发文宣布,全市各级公立医疗机构(含基层医疗卫生机构和村卫生室)从11月1日起,全面推行“两票制”。

同时强调,在潍坊市人民医院、潍坊益都中心医院两所三级甲等综合医院,对部分用量较大、市场供应渠道简单的药品试行“一票制”,使药品从生产企业直接到医疗机构。

北京市

2017年10月30日,北京发布《北京市公立医疗机构药品采购推行“两票制”实施方案(试行)》,明确实行“两票制”,将探索通过第三方支付平台,公立医疗机构与药品生产企业直接结算药品货款、药品生产企业与流通企业结算配送费用。

安徽省

11月20日,安徽5部门联合印发《安徽省公立医疗机构医用耗材采购“两票制”实施意见(试行)》通知,对医用耗材两票制推行做出明确规定。

通知明确,医疗器械生产企业可将医用耗材直接配送到二级以上公立医疗机构,也可委托医疗器械经营企业配送。

鼓励“一票制”,支持医疗器械生产企业与公立医疗机构之间直接结算医用耗材货款,医疗器械生产企业与医疗器械经营企业之间只结算配送费用,并按规定开具发票。

▍一票制消灭大批流通企业

一票制主要是指工业企业直接开票至终端,终端直接回款至工业。

中国药科大学国际医药商学院丁锦希教授就认为,“一票制”确实能减少流通环节,降低流通成本,但也将对信息沟通、物流配送、资金垫付、药品仓储、质量安全产生一定的影响。

在一票制模式下,由于货物和钱款的交易只在厂家和医院之间发生,商业公司的传统三大功能被人为砍掉两个,仅仅承担送货功能,相当于快递公司了。所以商业公司最先受到大冲击,死掉一批、转型一批!要么成为快递公司,要么成为厂家的销售团队。

更有激烈的观点认为,药品从企业直接到医院,已经不再需要流通企业了。一旦实施一票制,大批的流通企业将被消灭。

至于厂家,由于没有了商业公司的信息反馈功能,不得不把各项资源下沉至医院终端,运营成本或将增加。没有了商业公司的资金垫付,厂家也需直面医院的回款周期长、拖欠货款问题。

浙江省卫计委综合监督局局长吴朝晖就表示,在“一票制”下,生产企业必须减少流通环节,实现转型升级、优化组合,医疗机构也必须提高药品采购的集中度。

吴朝晖同时认为,“一票制”有望通过倒逼机制提升医药双方运行质量,一些自建营销队伍的生产企业完全可以实现“一票制”。

总而言之,无论是生产厂家还是流通企业,无论是实行一票制还是两票制,都是强者恒强,而弱者将会被淘汰!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-04 tulenzi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-04 陈吴1239
  4. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-03 137****9095

    henhao

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-02 1e0f8808m18(暂无匿称)

    一票制.压缩药品水份.好.

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-02 1e0e5a1fm42(暂无匿称)

    henhao

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1669279, encodeId=b04316692e90c, content=<a href='/topic/show?id=63a7193815f' target=_blank style='color:#2F92EE;'>#一票制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19381, encryptionId=63a7193815f, topicName=一票制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65b126545306, createdName=tulenzi, createdTime=Thu Jan 04 19:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365939, encodeId=4d8913659394b, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552412, encodeId=a0521552412f0, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Thu Jan 04 03:39:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275030, encodeId=8c0d2e50300e, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Wed Jan 03 11:44:34 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274784, encodeId=ddcd2e47840b, content=一票制.压缩药品水份.好., beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Tue Jan 02 15:57:13 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274756, encodeId=63252e475618, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=7dcf1938111, createdName=1e0e5a1fm42(暂无匿称), createdTime=Tue Jan 02 15:34:22 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274738, encodeId=d4a82e473862, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Tue Jan 02 13:48:37 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-02 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

相关资讯

药品跨区域联合采购潮涌 合作机制待完善

区域性的联合采购短期内会使高价格区域的利润被缩减,相关代理商操作空间减少。而从长期来看,区域壁垒被打破后有利于药价回归到相对合理的区间。

揭密!广东两票制正式方案的六大变化

广东两票制这次吸纳了药品生产企业、商业流通企业等各方的意见,整体政策较征求意见稿显得更为理性柔和。

北京公立医疗机构推“两票制”

北京市医改办、卫生计生委等10部门近日联合发布的《北京市公立医疗机构药品采购推行“两票制”实施方案(试行)》明确,北京市公立医疗机构采购的药品都将实施“两票制”。

福建改革药品供应制度

福建省政府近日出台该省《“十三五”深化医药卫生体制改革规划》提出,到2020年,通过实施一系列药品供应保障制度改革,推动各级各类医疗机构全面配备、优先使用基本药物,进一步规范和监管药品合理使用。

安徽放开医院二次议价!

对于“二次议价”,除辽宁省明令禁止外,福建、浙江、安徽、陕西、河南、湖北、重庆、上海、湖南、宁夏等省份都积极试点“二次议价”,有业内专家断言,“二次议价”一定会放开

今日“两票制”:山东提前,京沪严格要求

北京、上海同时发文,进一步对两票制的推行做出部署和要求;山东将在12月31日前全面启动执行“两票制”。